The study, known as 'EAGLE', did not improve overall survival compared with standard chemotherapy in patients with the hard-to-treat disease. AstraZeneca's ...
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2SDcFIU
The study, known as 'EAGLE', did not improve overall survival compared with standard chemotherapy in patients with the hard-to-treat disease. AstraZeneca's ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.